Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial
Gilead Sciences
Kenneth H Mayer; Jean-Michel Molina; Melanie A Thompson; Peter L Anderson; Karam C Mounzer; Joss J De Wet; Edwin DeJesus; Heiko Jessen; Robert M Grant; Peter J Ruane; Pamela Wong; Ramin Ebrahimi; Lijie Zhong; Anita Mathias; Christian Callebaut; Sean E Collins; Moupali Das; Scott McCallister; Diana M Brainard; Cynthia Brinson; Amanda Clarke; Pep Coll; Frank A Post; C Bradley Hare
Department of Biometrics, Gilead Sciences, Foster City, CA, USA. ; Department of Biometrics, Gilead Sciences, Foster City, CA, USA.